Cooper Companies | COO - Loan Capital

Stock Price
60.94
Daily Change
1.33 2.23%
Monthly
-12.27%
Yearly
-25.60%
Q2 Forecast
58.41

Cooper Companies reported $1.88B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Align Technology USD 0 0 Dec/2024
AtriCure USD 61M 865K Mar/2026
Avanos Medical USD 87.3M 3M Mar/2026
Bausch Health Companies USD 19.9B 720M Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dentsply International USD 2.01B 9M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 919.99M 406K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Novartis USD 29.59B 5.35B Dec/2025
ResMed USD 404.17M 245K Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Steris USD 1.81B 85.6M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Utah Medical Products USD 0 0 Mar/2022
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026